- Home
- NLY vs COO Comparison
NLY vs COO Comparison
Compare NLY & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLY
- COO
- Stock Information
- Founded
- NLY 1996
- COO 1980
- Country
- NLY United States
- COO United States
- Employees
- NLY N/A
- COO N/A
- Industry
- NLY Real Estate Investment Trusts
- COO Ophthalmic Goods
- Sector
- NLY Real Estate
- COO Health Care
- Exchange
- NLY Nasdaq
- COO Nasdaq
- Market Cap
- NLY 13.2B
- COO 14.2B
- IPO Year
- NLY 1997
- COO N/A
- Fundamental
- Price
- NLY $21.90
- COO $70.10
- Analyst Decision
- NLY Buy
- COO Buy
- Analyst Count
- NLY 9
- COO 11
- Target Price
- NLY $21.63
- COO $79.27
- AVG Volume (30 Days)
- NLY 6.8M
- COO 2.5M
- Earning Date
- NLY 10-22-2025
- COO 12-04-2025
- Dividend Yield
- NLY 12.79%
- COO N/A
- EPS Growth
- NLY N/A
- COO 13.33
- EPS
- NLY 2.19
- COO 2.04
- Revenue
- NLY $1,748,174,000.00
- COO $4,045,700,000.00
- Revenue This Year
- NLY $355.50
- COO $6.02
- Revenue Next Year
- NLY $5.70
- COO $5.81
- P/E Ratio
- NLY $9.98
- COO $34.37
- Revenue Growth
- NLY 275.23
- COO 6.35
- 52 Week Low
- NLY $16.60
- COO $61.78
- 52 Week High
- NLY $22.45
- COO $106.63
- Technical
- Relative Strength Index (RSI)
- NLY 63.00
- COO 47.47
- Support Level
- NLY $20.50
- COO $67.20
- Resistance Level
- NLY $21.22
- COO $70.12
- Average True Range (ATR)
- NLY 0.35
- COO 1.50
- MACD
- NLY 0.10
- COO -0.45
- Stochastic Oscillator
- NLY 96.87
- COO 31.28
About NLY Annaly Capital Management Inc.
Annaly Capital Management Inc is an American mortgage real estate investment trust. Its business objective is to generate net income for distribution to its stockholders and optimize its returns through prudent management of its diversified investment strategies. The company's reportable operating segments are; the Agency segment, which invests in Agency mortgage-backed securities collateralized by residential mortgages; the Residential Credit segment, which invests in non-Agency residential whole loans and securitized products within the residential and commercial markets; the Mortgage Servicing Rights segment; and Corporate & Other. Maximum revenue for the company is generated from its Agency segment.
About COO The Cooper Companies Inc.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.